ADK:TSV-DIAGNOS Inc (CAD)

COMMON STOCK | Health Information Services | TSV

Last Closing Price

CAD 0.17

Change

-0.01 (-2.94)%

Market Cap

CAD 0.01B

Volume

0.06M

Avg Analyst Target

CAD 0.98 (+490.91%)

Avg User Target

CAD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

DIAGNOS Inc (ADK) Stock Analysis:
Based on the DIAGNOS Inc stock forecasts from 2 analysts, the average analyst target price for DIAGNOS Inc is CAD 0.98 over the next 12 months. DIAGNOS Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of DIAGNOS Inc is Slightly Bearish, which is based on 3 positive signals and 4 negative signals. At the last closing, DIAGNOS Inc’s stock price was CAD 0.17. DIAGNOS Inc’s stock price has changed by -8.33% over the past week, -17.50% over the past month and -70.54% over the last year.

About

DIAGNOS Inc. provides software-based interpretation services primarily in Canada, the United States, Colombia, the United Arab Emirates, Bangladesh, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based softwar ...Read More

Currency: CAD

Country : Canada

Technical Indicators

Beta : 0.14

52 Week High : 0.65

Short Ratio : 0.01

52 Week Low : 0.17

Shorted Shares : 598

200 Day Moving Average : 0.37

Shorted Shares Previous Month : 14,002

50 Day Moving Average : 0.22

Short Percentage : 0.19%

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-05-25 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
RHT:CA Reliq Health Technologies Inc

-0.01 (-1.79%)

 CAD0.14B N/A N/A
DOC:CA CloudMD Software & Services In..

-0.01 (-2.44%)

 CAD0.12B N/A N/A
NEWU:CA Newtopia Inc

-0.02 (-10.00%)

 CAD0.02B N/A N/A
MNOW:CA Mednow Inc

+0.05 (+9.26%)

 CAD0.02B N/A 0.10
VISN:CA Binovi Technologies Corp

-0.01 (-5.56%)

 CAD0.01B N/A N/A
EYC:CA Binovi Technologies Corp

N/A

 CAD0.01B N/A N/A
CHS:CA Comprehensive Healthcare Syste..

N/A

 CAD8.54M N/A N/A
HMRK:CA Highmark Interactive Inc

+0.02 (+12.50%)

 CAD7.81M N/A N/A
KOVO:CA Kovo HealthTech Corporation

N/A

 CAD7.02M N/A N/A
VGL:CA Vigil Health Solutions Inc

N/A

 CAD6.81M 22.06 6.36

ETFs Containing ADK:CA

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Health Information Services)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -51.47% 46% F 12% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -51.47% 46% F 12% F
Trailing 12 Months  
Capital Gain -69.44% 38% F 12% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -69.44% 38% F 12% F
Trailing 5 Years  
Capital Gain -87.78% 33% F 6% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -87.78% 33% F 6% F
Average Annual (5 Year Horizon)  
Capital Gain 17.05% 89% B+ 53% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.05% 89% B+ 53% F
Risk Return Profile  
Volatility (Standard Deviation) 118.82% 22% F 32% F
Risk Adjusted Return 14.35% 89% B+ 41% F
Market Capitalization 0.01B 62% D- 48% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Health Information Services)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 57.52 22% F 6% F
Price / Cash Flow Ratio -8.66 77% C+ 44% F
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -363.28% 22% F 10% F
Return on Invested Capital -134.95% 45% F 12% F
Return on Assets -103.92% 25% F 13% F
Debt to Equity Ratio 3.46% 100% A+ 45% F
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 0.01 100% A+ 97% A+
Short Percent 0.19% 67% D+ 17% F
Beta 0.14 100% A+ 86% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date
New Post

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector